NCT06952361View on ClinicalTrials.gov

Evaluation of Alternative Transfusion Triggers in Hemodynamically Stable, Non-Ventilated Cancer Patients

CompletedOBSERVATIONAL
Enrollment

107

Participants

Timeline

Start Date

March 8, 2019

Primary Completion Date

November 24, 2021

Study Completion Date

November 24, 2021

Conditions
AnemiaBlood TransfusionCancerHemoglobinAlternative Physiological Transfusion Triggers
Interventions
PROCEDURE

Red blood cell transfusion

Standard red blood cell transfusion performed as part of routine clinical care. All participants received one or more units of RBCs based on a restrictive hemoglobin threshold. The transfusion protocol was not altered for the purpose of the study.

Trial Locations (1)

050000

Kazakh Institute of Oncology and Radiology, Almaty

All Listed Sponsors
lead

Ardak Arynov

OTHER

NCT06952361 - Evaluation of Alternative Transfusion Triggers in Hemodynamically Stable, Non-Ventilated Cancer Patients | Biotech Hunter | Biotech Hunter